In a single‑center registry, baseline and 1‑year distances below 350 meters identified higher‑risk patients with transthyretin amyloid cardiomyopathy; changes in distance were prognostic mainly with stable therapy.
As ASE marks its 50th anniversary in Nashville, the meeting will showcase the latest echocardiography research, updated guidelines, the Kalmanson Lecture, and discussions on workforce challenges.
A Chinese pilot study suggests that stereotactic body radiation therapy may represent a noninvasive alternative to septal reduction strategies in patients with drug-refractory hypertrophic obstructive cardiomyopathy (HOCM).
Gradient-boosted model shows higher diagnostic accuracy—especially for severe AS—in low-flow cases where guideline-based metrics often yield discordant results.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.